Group 1 - The core point of the news is that Zhonghong Medical's stock has experienced a significant decline since its IPO, currently trading at 13.51 yuan, down 2.60% [1] - Zhonghong Medical was listed on the Shenzhen Stock Exchange's ChiNext board on April 27, 2021, with an initial public offering (IPO) of 41.67 million shares at a price of 48.59 yuan per share [1] - The stock reached an all-time high of 159.80 yuan on its first trading day but has since entered a state of decline, currently trading below its IPO price [1] Group 2 - The total amount raised from the IPO was 2.025 billion yuan, with a net amount of 1.896 billion yuan after expenses, which was 1.317 billion yuan more than originally planned [1] - The initial fundraising plan aimed to raise 580 million yuan for a nitrile glove project and to supplement working capital [1] - The total issuance costs for the IPO were 128 million yuan, with Haitong Securities receiving 107 million yuan as underwriting fees [1] Group 3 - In the 2022 annual profit distribution announcement, Zhonghong Medical declared a cash dividend of 7.00 yuan per 10 shares and a capital reserve transfer of 3 shares for every 10 shares held, increasing the total share capital by 9 million shares [2] - For the 2021 annual profit distribution, the company distributed a cash dividend of 30.00 yuan per 10 shares and transferred 8 shares for every 10 shares held, increasing the total share capital by 13.33 million shares [2] - A future dividend plan for 2025 includes a cash distribution of 2.5 yuan per 10 shares and a transfer of 1 share for every 10 shares held, with the ex-dividend date set for June 27, 2025 [2]
中红医疗跌2.6% 上市即巅峰超募13亿